Cefadroxil 125mg Dry Syrup Franchise in Ahmedabad

Pediatric Antibiotic Medicine Supplier in Bangalore

Oral Antibiotic Syrup Distributor in Hyderabad

Respiratory & Skin Infection Syrup Franchise Opportunity in Jaipur

Urinary Tract Infection Syrup Stockist in Mumbai
Cefadroxil 125mg Dry Syrup Export & Manufacturing in Chandigarh

Home/Products /cefadroxil-125mg-dry-syrup

Droxifix 125 Dry Syrup

Composition : Cefadroxil (125mg) Dry Syrup

Dosage Form : Syrup

Packaging Type : Bottle

Packaging : 30 ml

Price : ₹1/-

Droxifix 125 Dry Syrup contains Cefadroxil 125mg, a broad-spectrum antibiotic formulated for pediatric and adult use. It is highly effective in managing bacterial infections of the respiratory tract, urinary system, and skin, providing rapid relief from fever, inflammation, and discomfort caused by bacterial pathogens.

The dry syrup formulation ensures easy preparation, accurate dosing, and excellent palatability for children, while maintaining reliable absorption and predictable antibacterial action. It is widely used in outpatient care, pediatrics, and hospital settings for both acute and chronic infections.

For distributors and resellers, Droxifix 125 Dry Syrup is a high-demand antibiotic product, consistently prescribed in hospitals, clinics, and pediatric care centers. Its applicability across multiple infection types ensures steady sales and recurring demand throughout the year.

Adding Droxifix 125 Dry Syrup to your product portfolio strengthens your antibiotics and pediatric care segment, creating opportunities for bulk institutional supply, government tenders, hospital chains, export markets, and third-party manufacturing. Its essential role in treating common bacterial infections makes it a profitable and strategically important product for any medical distributor.


Read More

About the Product

Droxifix 125 Dry Syrup contains Cefadroxil 125mg, a broad-spectrum antibiotic formulated for pediatric and adult use. It is highly effective in managing bacterial infections of the respiratory tract, urinary system, and skin, providing rapid relief from fever, inflammation, and discomfort caused by bacterial pathogens.

The dry syrup formulation ensures easy preparation, accurate dosing, and excellent palatability for children, while maintaining reliable absorption and predictable antibacterial action. It is widely used in outpatient care, pediatrics, and hospital settings for both acute and chronic infections.

For distributors and resellers, Droxifix 125 Dry Syrup is a high-demand antibiotic product, consistently prescribed in hospitals, clinics, and pediatric care centers. Its applicability across multiple infection types ensures steady sales and recurring demand throughout the year.

Adding Droxifix 125 Dry Syrup to your product portfolio strengthens your antibiotics and pediatric care segment, creating opportunities for bulk institutional supply, government tenders, hospital chains, export markets, and third-party manufacturing. Its essential role in treating common bacterial infections makes it a profitable and strategically important product for any medical distributor.


Some patients may experience nausea, vomiting, diarrhea, abdominal discomfort, or mild skin rash. Rarely, severe allergic reactions, liver enzyme abnormalities, or antibiotic-associated colitis may occur.

It is indicated for the treatment of respiratory tract infections, urinary tract infections, skin and soft tissue infections, and other bacterial infections. It helps relieve symptoms and supports the elimination of pathogenic bacteria.

Use only under medical supervision. Avoid in patients with known hypersensitivity to cephalosporins or penicillins. Complete the full course even if symptoms improve early.

Store the dry syrup in a cool, dry place below 25°C. After reconstitution, store the syrup in the refrigerator and use within the prescribed duration. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation